Solv Multi-Pass Hemodialysis System In-Center Clinical Study
Recruiting · Greenville, South Carolina
Always free
Study care at no cost to you
For your time and travel
Many studies pay you back
Most need no insurance or papers
Legal status usually isn't required; we'll tell you each study's requirements
Interpreters available
Ask for your language
Your choice
Voluntary — you can stop anytime
What is this study?
Solv In-Center clinical study is a pre-market, prospective, multicenter, single arm, open-label clinical study. The patient population will include patients with kidney failure or insufficiency requiring hemodialysis and/or ultrafiltration.
It is , overseen by an independent and licensed medical staff.
Read the full clinical description
Solv In-Center clinical study is a pre-market, prospective, multicenter, single arm, open-label clinical study. The patient population will include patients with kidney failure or insufficiency requiring hemodialysis and/or ultrafiltration. Eligibility will be open to incident dialysis patients and patients currently receiving HD in an in-center environment. All vascular access types including AV-fistula, AV-graft, and tunneled hemodialysis catheters.
Who this study is looking for
In plain language, from the study's own rules. The study team confirms the full details with you — this isn't a final yes or no.
✅ You may be able to join if…
- •Adults age 18 or older
- •People on in-center dialysis who need hemodialysis and/or ultrafiltration
- •You can meet one of these kidney-disease situations: stable on maintenance hemodialysis for at least 3 months, newly starting hemodialysis, or you need to switch from peritoneal dialysis to hemodialysis
- •You have adequate vascular access and can provide blood flow of at least 300 mL/min
- •You understand the study and agree to follow the study plan and return for all required visits
🚫 You may not be able to join if…
- •If your baseline dry weight is ≤ 60 kg or ≥ 110 kg
- •If you have a documented history of not following scheduled dialysis sessions or clinic visits
- •If a living kidney transplant is planned within the next 2 months, or if you plan to change to peritoneal dialysis within 2 months, or if you require single needle dialysis therapy
- •If you have unstable electrolytes or acid-base balance, or uncontrolled/heavy medical instability (such as repeated very low/high blood pressure in the past 30 days, shock in the past 30 days, or significant intradialytic hypotension in the past 30 days)
- •If you have certain health problems like active infection, hepatitis B/C or HIV, pregnancy or breastfeeding (or you refuse contraception), hemoglobin < 9 g/dl in the past 30 days, active seizures in the last 6 months, or known bleeding/clotting problems; also if you had major surgery or a major adverse cardiac event within 3 months or have had recent access procedures (details in study)
Are you a good fit?
Simplified highlights. The study team always confirms the full details with you.
- ✓Adults roughly 18 and older
- !Some conditions may not be a fit: Heart / cardiovascular disease, High blood pressure
- !Not for people who are pregnant or breastfeeding
What to expect, step by step
- 1
Usually a few weeks
The study team checks whether the study is a good fit for you, with a visit and sometimes lab tests. You can ask any questions before deciding.
- 2
Treatment
If you join and choose to continue, you receive the study treatment and are watched closely by medical staff.
- 3
Follow-up
After treatment, the team checks on your health and confirms the visit schedule with you. You can leave the study at any point.
Has this treatment been tested before?
The study team can share what safety testing has been done so far.
What you need to know before you apply
What is this study testing?+
Solv In-Center clinical study is a pre-market, prospective, multicenter, single arm, open-label clinical study. The patient population will include patients with kidney failure or insufficiency requiring hemodialysis and/or ultrafiltration.
Is it safe? Who makes sure of that?+
This is a research study. Every study is reviewed and monitored by an independent ethics board (called an IRB) whose job is to protect participants, and care is overseen by licensed medical staff. You'll be told the known risks before you agree to anything, and you can stop at any time.
Will I get a placebo instead of the real treatment?+
Some studies compare a treatment against a placebo (an inactive version), and some don't. If this one does, the study team will explain your chances of receiving the active treatment before you decide. Nothing is hidden from you.
Do I have to stop taking my current medications?+
It depends on the study. Some let you stay on your current medications and some ask you to adjust them. Never stop a medication on your own — the study team will review everything with you first.
Does it cost anything? Will I be paid?+
Study-related care is provided at no cost to you. Some studies also pay for your time; the coordinator can tell you if this one does. You should never be asked to pay to take part.
Do I need insurance? Will anyone ask about my immigration status?+
No. You do not need health insurance to take part in a research study, and you will not be asked about your immigration status to join. Taking part is about whether you're a medical fit for the study.
What if English isn't my first language?+
You have the right to understand everything before you agree. Study sites can often provide materials or an interpreter in your language — you can ask the coordinator for one.
Is my information private?+
Yes. Your health information is only shared with the study sites you choose to be contacted by, and only to help match and enroll you. It is never sold, and you can ask us to delete it at any time.
Some requirements (like specific lab values or timing) are confirmed directly by the study team, not by us.
Source: ClinicalTrials.gov · NCT07216885 · Locations: South Carolina